Abstract
The present disclosure relates to N-(5-Chloropyridin-2-yl)-N′-[(1S,2R,4S)-4-(N,N-dimethylcarbamoyl)-2-(5-methyl4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl] oxamide mono(4-methylbenzenesulfonate) monohydrate, is represented by following structural formula (I).
The present disclosure relates to a process for the preparation of an intermediate of compound of formula (I), the intermediate is represented by following structural formula (II).
The present disclosure relates to a process for the preparation of an intermediate of compound of formula (I), the intermediate is represented by following structural formula (III).
The present disclosure relates to a process for the preparation of an intermediate of compound of formula (I), the intermediate is represented by following structural formula (IV).
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
Lee Pharma Limited, "IMPROVED PROCESS FOR THE PREPARATION OF AN INTERMEDIATE COMPOUNDS OF AN ANTICOAGULANT", Technical Disclosure Commons, ()
https://www.tdcommons.org/dpubs_series/11700